ProKidney Change To Netincome from 2010 to 2025

PROK Stock  USD 0.97  0.01  1.02%   
ProKidney Corp Change To Netincome yearly trend continues to be quite stable with very little volatility. Change To Netincome may rise above about 89.9 M this year. From the period between 2010 and 2025, ProKidney Corp, Change To Netincome regression line of its data series had standard deviation of  36,213,224 and standard deviation of  36,213,224. View All Fundamentals
 
Change To Netincome  
First Reported
2010-12-31
Previous Quarter
85.6 M
Current Value
89.9 M
Quarterly Volatility
36.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check ProKidney Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ProKidney Corp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.4 M, Interest Expense of 13.1 K or Selling General Administrative of 29.4 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. ProKidney financial statements analysis is a perfect complement when working with ProKidney Corp Valuation or Volatility modules.
  
Check out the analysis of ProKidney Corp Correlation against competitors.
For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.

Latest ProKidney Corp's Change To Netincome Growth Pattern

Below is the plot of the Change To Netincome of ProKidney Corp over the last few years. It is ProKidney Corp's Change To Netincome historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ProKidney Corp's overall financial position and show how it may be relating to other accounts over time.
Change To Netincome10 Years Trend
Slightly volatile
   Change To Netincome   
730.699.74.85.89.-4%10554%15%5%100%
       Timeline  

ProKidney Change To Netincome Regression Statistics

Arithmetic Mean20,681,729
Geometric Mean1,859,565
Coefficient Of Variation175.10
Mean Deviation30,221,469
Median498,000
Standard Deviation36,213,224
Sample Variance1311.4T
Range89.4M
R-Value0.76
Mean Square Error593.8T
R-Squared0.58
Significance0.0006
Slope5,779,668
Total Sum of Squares19671T

ProKidney Change To Netincome History

202589.9 M
202485.6 M
202274.5 M
2021699 K
2020730 K

About ProKidney Corp Financial Statements

ProKidney Corp investors utilize fundamental indicators, such as Change To Netincome, to predict how ProKidney Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Change To Netincome85.6 M89.9 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether ProKidney Corp is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if ProKidney Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Prokidney Corp Stock. Highlighted below are key reports to facilitate an investment decision about Prokidney Corp Stock:
Check out the analysis of ProKidney Corp Correlation against competitors.
For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProKidney Corp. If investors know ProKidney will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProKidney Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.54)
Return On Assets
(0.20)
Return On Equity
(0.31)
The market value of ProKidney Corp is measured differently than its book value, which is the value of ProKidney that is recorded on the company's balance sheet. Investors also form their own opinion of ProKidney Corp's value that differs from its market value or its book value, called intrinsic value, which is ProKidney Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProKidney Corp's market value can be influenced by many factors that don't directly affect ProKidney Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProKidney Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProKidney Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProKidney Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
News Freq…Investor S…